Web13 sep. 2024 · Hereditary thrombotic thrombocytopenic purpura (TTP) Immune TTP: Initial treatment; Immune TTP: Management following recovery from an acute episode and … Web1 jan. 2006 · In all relapses, steroids were always prescribed, whereas a standard dose of RTX (375 mg/m 2 weekly for four weeks) was given to three patients. ... Focus on Key …
Pixantrone for the treatment of adult patients with relapsed or ...
WebThis study describes the clinical spectrum and response to treatment and explores the risks of relapse in a cohort of patients. Methods Patients treated for TTP at the Clinical … WebIn the present case, a 62-year-old male patient was diagnosed with relapsed and refractory multiple myeloma (RRMM). Treated with CART-CD19/BCMA therapy, his symptoms remitted, during which occasional but severe CRS associated with coagulation disorder … dalby hospital
Remission of Severe, Relapsed, and Refractory TTP after ... - Hindawi
Web1. Introduction. The clinical features of thrombotic thrombocytopenic purpura (TTP) often include hemolytic anemia with abundant schistocytes, thrombocytopenia, renal injury, … Web10 okt. 2024 · Patients with TTP are treated with rituximab, an injection into the vein, in the acute episodes of the disease and also later in the patient pathway to prevent relapse. … Web18 jun. 2015 · Vincristine has also been used in relapsed or refractory TTP with response rates of 50% to 87%.59, 60, 61 The side-effect profile includes mild peripheral paresthesias, muscle weakness, paralytic ileus, leukopenia, and transient alopecia. 62 Vincristine may work better when used in the initial treatment of patients with TTP, rather ... dalby high school